Parenteral iron therapy

Israel Medical Association Journal

Volumn 10, Issue 5, 2008, Pages 372-373

  Kaplinsky, Chaim ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Intravenous iron therapy; Iron deficiency anemia; Molecular control of iron absorption

Indexed keywords

APOTRANSFERRIN; ASCORBIC ACID; CARBOHYDRATE IRON COLLOID COMPLEX; CERULOPLASMIN; FERRIC CARBOXYMALTOSE; FERRIC GLUCONATE; FERRIC HYDROXIDE SUCROSE; FERRITIN; FERROPORTIN 1; FERROUS GLUCONATE; FERROUS SULFATE; HEMOGLOBIN; HEPCIDIN; HEPHESIN; IRON; IRON DERIVATIVE; IRON SALT; MESSENGER RNA; MYOGLOBIN; POLYSACCHARIDE IRON; TRANSFERRIN RECEPTOR;

AEROBIC METABOLISM; BLEEDING; BLOATING; CELL GROWTH; CELL PROLIFERATION; CLINICAL TRIAL; DIARRHEA; DISTRESS SYNDROME; DRUG ABSORPTION; DRUG POTENTIATION; EDITORIAL; ENERGY METABOLISM; ERYTHROPOIESIS; FLUSHING; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOTENSION; IRON ABSORPTION; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON THERAPY; NAUSEA; OXIDATION REDUCTION REACTION; OXYGEN TRANSPORT; PATIENT COMPLIANCE; SIDE EFFECT; VOMITING;

ADMINISTRATION, ORAL; ANEMIA, IRON-DEFICIENCY; FERRIC COMPOUNDS; HEMATINICS; HUMANS; INFUSIONS, INTRAVENOUS; INFUSIONS, PARENTERAL; IRON; PATIENT COMPLIANCE;

EID: 46149091309     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (15)

1. Hershko C, Ronson A, Souroujon M, Maschler I, Heyd J, Patz J. Hematologist's view of unexplained iron deficiency anemia in males: impact of Helicobacter pylori eradication. Blood Cells Molecul Dis 2007;38:45-53.
2. Hershko C, Ronson A, Souroujon M, Maschler I, Heyd J, Patz J. variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency Lo cobalamin depletion Blood 2006;107:1673-9.
3. Bothwell TH, Charlton RW. Cook JD. Finch CA. Iron Metabolism in Man. Oxford, UK: Blackwell Scientific Publications, 1979.
4. Andrews NC. Iron homeostasis: insights from genetics and animal models. Nature Rev Genet 2000;1:208-16.
5. Matthias W, Hentze MW, Muckenthaler MU, Andrews, NC. Balancing acts: molecular control of mammalian iron metabolism. Cell 2004;117:285-97.
6. Andrews NC. Molecular control of iron metabolism. Clin Hematol 2005;18:156-69.
7. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003;102:783-8.
8. Bridle KR, Frazer DM, Wilkins SJ, et al. Disrupted hepcidin regulation in HFE-associated hemochromatosis and the liver as a regulator of body iron homeostasis. Lancet 2003;361:669-73.
9. Pinsk V, Levy J, Moser A, Yerushalmi B, Kapelushnik J. Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia. IMAJ 2008;10:335-8.
10. Sunder-Plassmann G, Horl WH. Safety of intravenous injection of iron saccharate in haemodialysis patients. Nephrol Dial Transplant 1996;11:1797-802.
11. Van Wyck DB, Danielson BG, Aronoff GR. Making sense: a scientific approach to intravenous iron therapy. J Am Soc Nephrol 2004;15:91-4.
12. Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A. intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia. Obstet Gynecol 2007;110:267-78.
13. Ciacci C, Sabbatini F, Cavallaro R, et al. Helicobacter pylori impairs iron absorption in infected individuals. Dig Liver Dis 2004; 36:455-60.
14. De Morais MB, Suzuki HU, Corral JN, Machado NL, Neto UF. Asymptomatic giardiasis does not affect iron absorption in children with iron deficiency anemia. J Am Coll Nutr 1996;15:434-8.
15. Finberg KE, Heeney MM, Campagna DR, et al. Mutations in TMPRSS6 cause iron- refractory iron deficiency anemia (IRIDA). Nat Genet 2008;40:569-71